Hepatobiliary Surgery Division, IRCCS San Raffaele Hospital, Milano, Italy.
J Hepatobiliary Pancreat Sci. 2020 Aug;27(8):510-521. doi: 10.1002/jhbp.736. Epub 2020 Apr 16.
The aim of the present study was to analyze the outcome of laparoscopic approach specifically in patients with Intermediate-stage disease and to define the differential benefit with Early-stage patients.
Six hundred twenty-two resections for HCC were dichotomized according to staging (Early and Intermediate) and to approach and then matched in a 1:1 ratio using propensity scores to obtain four groups (E-MILS and E-Open, including 104 patients respectively; Int-MILS and Int-Open, including 142 patients, respectively). The differential benefit associated with the minimally invasive technique was evaluated between intermediate-stage and early-stage patients taking into account blood loss and morbidity rate as outcome indicators.
Laparoscopic approach resulted in a statistically significant lower blood loss, reduced morbidity, reduced incidence of hepatic decompensation and shorter time for functional recover and length of stay. The evaluation of the differential benefit showed a greater advantage of laparoscopic approach in Intermediate-stage patients compared with Early-stage patients, both in terms of blood loss and morbidity rate.
The favorable biological scenario associated with laparoscopic approach allows to obtain enhanced benefits in the setting of more advanced liver disease. The push towards minimal invasiveness and the incremental benefit associated with it could potentially promote stage migration in suitable patients.
本研究旨在分析腹腔镜方法在中危期患者中的治疗效果,并确定与早期患者相比的差异获益。
根据分期(早期和中危期)和方法将 622 例 HCC 切除术分为两组,然后使用倾向评分进行 1:1 配对,得到四组(E-MILS 和 E-Open,分别包括 104 例患者;Int-MILS 和 Int-Open,分别包括 142 例患者)。考虑到出血量和并发症发生率作为结果指标,评估微创技术与中危期和早期患者相关的差异获益。
腹腔镜方法在出血量、并发症发生率、肝功能失代偿发生率、功能恢复时间和住院时间方面具有统计学显著优势。评估差异获益显示,腹腔镜方法在中危期患者中比早期患者具有更大的优势,无论是在出血量还是并发症发生率方面。
腹腔镜方法相关的有利生物学情况可在更严重的肝病患者中获得更大的获益。向微创化推进及其相关的增量获益可能会促使适合的患者分期迁移。